Summary:
Hypogonadotropic hypogonadism is a condition where the body produces insufficient sex hormones due to a lack of stimulation from the pituitary gland. This results from low levels of gonadotropins—luteinizing hormone (LH) and follicle-stimulating hormone (FSH)—which are essential for normal reproductive function. It can lead to delayed puberty, infertility, and other symptoms related to low testosterone or estrogen levels.
This study will assess the efficacy of a new study medication for Hypogonadotropic Hypogonadism. Join the study and help advance research.
Qualified Participants Must:
• 18-49 years of age
•
Fasting morning (before 10 AM) serum total testosterone concentration <300 ng/dL on two occasions, of which one sample must be at screening and the other sample must be at or within 24 months prior to screening.
Qualified Participants May Receive:
- Compensation for those who qualify
- Medication at NO COST to you or your insurance
- No Cost medical care